Tag: Abattis

November 21, 2017

Emerald Health Completes Investment Deal With Northern Vine

Emerald Health Therapeutics announced it completed an investment deal worth 2.5 million into Northern Vine Canada in order to get...
October 26, 2017

Emerald Health Therapeutics to Acquire Control of Licensed Dealer Northern Vine

Emerald Health Therapeutics signed an agreement with Northern Vine Canada and Abattis Bioceuticals to invest $2.5 million into Northern Vine...
October 16, 2017

Alumina Partners commits up to $6 mln to Naturally Splendid and Closes First Tranche Investment. Naturally Splendid also Extends Closing of Prosnack Acquisition.

Naturally Splendid (TSXV:NSP) Enterprises Ltd. is pleased to announce that on October 13, 2017, the Company entered into a non-binding agreement...
August 21, 2017

Abattis Announces Receipt of Cultivation License by LP Partner

Abattis Bioceuticals and its majority-owned testing and laboratory subsidiary, Northern Vine Canada announced their LP investment partner, Experion Biotechnologies received...
May 10, 2017

Northern Vine Labs Expands Its Sales Team

Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE: ATT) (OTCQB: ATTBF) is pleased to announce the addition of Siobhan McCarthy...
April 26, 2017

Abattis Inks Distribution Deal for Extraction Tech

Abattis Bioceuticals will have access to Suzhou Raybot Material Tech's extraction technology thanks to a new distribution agreement between the...